
Chemcrux Enterp. Sees Revision in Market Evaluation Amidst Challenging Financial Trends
2025-12-04 11:08:33Chemcrux Enterp., a microcap player in the Specialty Chemicals sector, has experienced a revision in its market evaluation reflecting recent changes across key analytical parameters. This shift comes amid persistent financial challenges and subdued stock performance over the past year.
Read MoreIs Chemcrux Enterp. overvalued or undervalued?
2025-11-21 08:52:05Valuation Metrics and Market Position Chemcrux Enterp. currently trades at a price of ₹114.00, having seen a recent decline from its previous close of ₹115.35. The stock’s 52-week range spans from ₹100.20 to ₹199.75, indicating significant volatility and a notable correction from its highs. The company’s price-to-earnings (PE) ratio stands at an elevated 92.25, which is high by conventional standards but comparatively fair within its peer group in the specialty chemicals industry. Other valuation multiples such as the enterprise value to EBITDA (EV/EBITDA) ratio at 22.72 and price-to-book value of 2.26 further support the notion of a fair valuation. These figures suggest that while the stock is not cheap, it is not excessively overpriced relative to its earnings and bo...
Read MoreWhy is Chemcrux Enterp. falling/rising?
2025-11-21 00:50:37Recent Price Action and Market Performance Chemcrux Enterprises opened the trading session with a notable gap up of 2.99%, signalling early optimism among investors. The stock even touched an intraday high of ₹119.90, representing a 3.94% gain from the previous close. However, this positive momentum was not sustained throughout the day. The share price declined to an intraday low of ₹112.55, down 2.43%, before settling at ₹114.00 by the market close. The weighted average price indicates that a greater volume of shares traded closer to the lower end of the day’s price range, suggesting selling pressure intensified as the session progressed. Technical Indicators Point to Continued Weakness Technically, Chemcrux Enterprises is trading below all key...
Read MoreIs Chemcrux Enterp. overvalued or undervalued?
2025-11-09 08:12:04As of 7 November 2025, Chemcrux Enterprises has moved from a fair to an expensive valuation grade. The company is currently overvalued, with a PE ratio of 103.22, an EV to EBIT of 35.45, and a Price to Book Value of 0.25. These metrics indicate a significant premium compared to its peers, such as Godrej Industries, which has a PE of 35.95 and an EV to EBITDA of 28.96, and Atul, which is fairly valued with a PE of 30.84. The valuation of Chemcrux is concerning, particularly when considering its low ROE of 0.24% and ROCE of 0.56%, which suggest inefficiencies in generating returns relative to its high market price. Additionally, the company has underperformed against the Sensex, with a year-to-date return of -24.57% compared to the Sensex's 6.50%, further reinforcing the notion that Chemcrux is not a compelling investment at its current valuation....
Read MoreIs Chemcrux Enterp. overvalued or undervalued?
2025-11-08 08:12:07As of 7 November 2025, Chemcrux Enterprises has moved from a fair to an expensive valuation grade. The company is currently considered overvalued, with a PE ratio of 103.22, an EV to EBITDA of 16.95, and a Price to Book Value of 0.25. These ratios indicate that the stock is trading at a premium compared to its earnings and cash flow generation capabilities. In comparison to its peers, Chemcrux's valuation stands out significantly. For instance, Solar Industries has a PE ratio of 97.45 and an EV to EBITDA of 59.96, while Godrej Industries, deemed attractive, has a PE ratio of 35.95 and an EV to EBITDA of 28.96. The stark difference in these ratios suggests that Chemcrux is not only overvalued relative to its direct competitors but also lacks the financial metrics to justify its high valuation. Moreover, the company's recent stock performance shows a YTD decline of 24.57%, contrasting sharply with the Sensex...
Read MoreAre Chemcrux Enterp. latest results good or bad?
2025-11-07 19:24:19Chemcrux Enterprises' latest financial results for Q2 FY26 indicate significant operational challenges. The company reported net sales of ₹17.75 crores, reflecting a marginal decline of 0.06% year-on-year, which is consistent with the stagnant growth trend observed over recent periods. However, the company's net profit plummeted to ₹0.21 crores, marking an 81.74% decrease compared to the previous year, highlighting severe profitability issues. The operating margin contracted to 10.14%, down from 13.29% a year earlier, indicating a notable erosion in operational efficiency. Additionally, the profit after tax (PAT) margin fell sharply to 1.18%, down from 6.48% in the same quarter last year, further underscoring the operational stress the company is experiencing. This decline in profitability is compounded by a significant increase in interest costs, which rose by 151.52% year-on-year to ₹0.83 crores, consumi...
Read More
Chemcrux Enterprises Faces Operational Challenges Amidst Stabilizing Financial Metrics
2025-11-07 08:00:29Chemcrux Enterprises has reported a flat financial performance for the quarter ending September 2025, with a notable shift in its metrics. However, the company faces challenges, particularly a significant decline in profit before tax. Its stock performance has been mixed compared to the Sensex, highlighting ongoing operational difficulties.
Read MoreHow has been the historical performance of Chemcrux Enterp.?
2025-11-06 22:59:10Answer: The historical performance of Chemcrux Enterp. shows a declining trend in key financial metrics over the past three years. Breakdown: Chemcrux Enterp. has experienced a decrease in net sales, dropping from 95.15 Cr in Mar'23 to 70.01 Cr in Mar'25. Total operating income followed a similar trend, declining from 95.15 Cr in Mar'23 to 70.01 Cr in Mar'25. The total expenditure, excluding depreciation, also decreased from 73.70 Cr in Mar'23 to 60.78 Cr in Mar'25. Operating profit (PBDIT) has seen a significant decline from 22.50 Cr in Mar'23 to 10.72 Cr in Mar'25, while profit before tax fell from 19.65 Cr to 5.77 Cr in the same period. Consequently, profit after tax decreased from 14.36 Cr in Mar'23 to 3.91 Cr in Mar'25, reflecting a drop in earnings per share from 9.7 to 2.64. The company's total assets increased from 93.22 Cr in Mar'23 to 127.05 Cr in Mar'25, alongside a rise in total debt from 13.42...
Read MoreWhy is Chemcrux Enterp. falling/rising?
2025-11-06 22:59:07As of 06-Nov, Chemcrux Enterprises Ltd is experiencing a decline in its stock price, currently at Rs 121.35, which reflects a decrease of Rs 6.6 or 5.16%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 14.48% during this period. Although it opened with a gain of 5.47% today and reached an intraday high of Rs 135.6, it also hit a low of Rs 120.05, indicating significant volatility with a wide trading range of Rs 15.55. The stock's performance over the past week shows a decline of 8.21%, and it has underperformed against the sector by 4.18%. Additionally, the stock's year-to-date return is down 28.24%, and it has seen a substantial drop of 69.24% over the past three years. In the broader market context, the Sensex has only declined by 1.30% over the past week, highlighting that Chemcrux's short-term performance is significantly worse t...
Read MoreBoard Meeting Intimation for Board Meeting On 05Th February 2026
29-Jan-2026 | Source : BSEChemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 inter alia to consider and approve 1. Unaudited Financial Results for the quarter and nine months ended 31st December 2025 for F.Y. 2025-26 and other related matters thereto. 2. To consider any other business /agenda
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
12-Jan-2026 | Source : BSECertificate u/r 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31st December 2025
Closure of Trading Window
27-Dec-2025 | Source : BSEIntimation of Closure of trading Window
Corporate Actions
No Upcoming Board Meetings
Chemcrux Enterprises Ltd has declared 10% dividend, ex-date: 17 Sep 25
No Splits history available
Chemcrux Enterprises Ltd has announced 2:1 bonus issue, ex-date: 06 Sep 21
No Rights history available